SOURCE: Quture International, Inc.

Quture International, Inc.

July 11, 2012 08:00 ET

Quture/TCLN & Springhill Medical Center Jointly Announce Sale of Software License to Qualoptima

Company Contracts for First Revenue to Quture for New Product on InterSystems' Platform

DAYTONA BEACH, FL and SPRINGHILL, LA--(Marketwire - Jul 11, 2012) - Quture International, Inc. (OTCQB: TCLN) (PINKSHEETS: TCLN) ("Quture") and Springhill Medical Center jointly announce the purchase of a license to Quture's new clinical performance measurement product, QualOptima. Springhill has licensed Quture's previous product QReview for over five years. Now, with new regulatory mandates, hospitals previously using peer review software must change to performance measurement. Springhill selected Quture based on their successful experience with the company's previous product and Quture's expertise in clinical performance measurement. Quture's new "transformative" and "disruptive" tool is introducing electronic performance measurement to empower hospitals and surgery centers to measure clinical performance on the InterSystems Corporation ( technology platform. Rural medical centers such as Springhill are now able to replace labor-intensive manual processes with electronic data capture and analytics, while integrating their peer review and performance measurement processes.

"We have had an excellent relationship with Quture and their previous QReview product," said Marilyn Mow, Assistant Administrator of Springhill Medical Center. "We are excited to purchase this new product to begin transitioning from existing labor-intensive, anecdotal, and required quality and risk management processes to electronic data analysis. The new Joint Commission standards created our need to change to a performance measurement product. We immediately contacted our vendor, now their new corporation Quture, and we are excited that the Company has developed this remarkable new software solution. We believe our hospital and the community and patients we serve will benefit extraordinarily by Quture's new analytics system."

Quture has completed migration from their former peer review product onto the InterSystems technology platform and integrated the performance measurement technology and intellectual property demonstrated at the University of Miami with InterSystems. InterSystems' interface engine Ensemble® is used for data integration to capture clinical data electronic medical records and disparate databases into the InterSystems CACHÉ® object-oriented database. The InterSystems platform is aptly-suited to harness and support the power of Quture's intellectual property. Additionally, InterSystems' DeepSee™ dashboard for embedded real-time business intelligence and Zen report writer complete the platform package for health care enterprise management that is so desperately needed by physicians, clinicians, administration, boards and the quality and patient safety professionals in hospitals and physician groups in America and internationally. 

"We have now achieved a major milestone to move from product development to a revenue-generating operational company," said Landon Feazell, CEO of Quture International. "We are proud that Springhill has selected Quture to continue meeting their needs for compliance with mandated standards for measuring clinical performance. Transitioning from peer review to performance measurement has been the core competence of our companies for more than 35 years. We are excited to be involved in the global movement to improve care, transform quality of care endeavors, and reduce costs using clinical performance measurement. We deeply appreciate the efforts and successes with InterSystems to achieve this remarkable milestone on their incredible technology platform."


Quture International, Inc. is an emerging growth company positioned to become the leading clinical knowledge company in the world. The core competence of Quture is clinical performance enhancement to achieve optimal patient outcomes. Quture's brand is centered on the value proposition of trust, transparency and independence. As the free enterprise solution to improving health and health care while reducing costs, Quture is comprised of a subsidiaries in North America and Europe for the operations of its software technology solutions, plans for a "beyond data" consulting and knowledge applications company, as well as plans for a personalized, proactive, and predictive medicine company with a virtual community of members. These subsidiaries will all be affiliated with the Qx Medical Exchange, which the Company intends to become the largest medical and health exchange in the world. Quture International is a Nevada corporation currently trading under the symbol TCLN.


Springhill Medical Center is a 58 bed facility offering Medical/Surgical, Geriatric Psychiatric, ICU, and ER services. In addition Springhill Medical Center offers full service Lab, X-Ray, Physical Therapy and Respiratory departments. Two Rural Health Clinics are home to 10 full-time healthcare providers and various other specialty providers that come on a regular basis. The medical center serves a large area of northwest Louisiana and parts of Arkansas. SMC's mission is "Patient Centered Care From Our Family To Yours." SMC's vision is "To be every patient's first choice for healthcare excellence. We will adapt and expand services to create healthier communities."

This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. There is no assurance that a definitive agreement will be completed.

Contact Information

  • For Further Information Contact:
    Constellation Asset Advisors, Inc.
    Jens Dalsgaard
    +1 (415) 524-8500

    Mele Telitz
    Director of Communications